Bank Of Nova Scotia Natera, Inc. Transaction History

Bank Of Nova Scotia

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $2.49 Million - $3.58 Million	-57,337 Reduced 46.04%	67,199 $2.97 Million
Q2 2023 Aug 03, 2023	BUY	$47.08 - $55.16 $969,047 - $1.14 Million	20,583 Added 19.8%	124,536 $6.06 Million
Q1 2023 May 11, 2023	SELL	$36.57 - $58.29 $471,972 - $752,290	-12,906 Reduced 11.04%	103,953 $5.77 Million
Q4 2022 Feb 09, 2023	SELL	$34.17 - $47.91 $16.9 Million - $23.7 Million	-494,680 Reduced 80.89%	116,859 $4.69 Million
Q3 2022 Nov 10, 2022	BUY	$36.93 - $56.68 $7.64 Million - $11.7 Million	206,969 Added 51.16%	611,539 $26.8 Million
Q2 2022 Aug 05, 2022	SELL	$28.13 - $44.54 $14.3 Million - $22.6 Million	-508,357 Reduced 55.68%	404,570 $14.3 Million
Q1 2022 May 09, 2022	BUY	$30.32 - $91.33 $24.9 Million - $74.9 Million	819,597 Added 878.17%	912,927 $37.1 Million
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $8.05 Million - $11.1 Million	93,330 New	93,330 $8.72 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.